Creating a Global Company

ANDA & NDA Pipeline ANDAS Filed and Approved (Cumulative) 595 600 584 561 571 581 512 501 483 453 427 422 FY17 FY18 FY19 SUN PHARMA NDA Filed and Approved (Cumulative) 41 42 39 36 FY20 FY21 Q3FY22 FY17 FY18 Cumulative Products Filed Cumulative Products Approved 59 52 42 FY19 64 66 50 60 55 55 53 FY20 FY21 Q3FY22 I Cumulative Products Filed Cumulative Products Approved (All data as of 31-Dec-2021) 22

View entire presentation